Today Mary Jo feels pretty good and is looking forward to meeting for lunch with her good friend Lu Ann.
Mary Jo had her weekly Herceptin treatment on Monday morning at Dr. Gall's, Minnesota Oncology office. This week she tolerated the Herceptin well with little of the adverse side effects. Next Monday, Mary Jo will be given chemo treatment number five of "TC" (Taxotere and Carboplatian, the main chemo agents along with Aloxi, Dexameth, Amend, and Newlasta as boosters). This will be the fifth cycle of the eight cycle regiment.
Mary Jo's mom, Diane was there as usual on Monday, to sit with MJ and I to keep us company during the Herceptin treatment. Diane has been so supportive to us through this whole process. It was also good to see Mary Jo's good friend Jamie at the "spa". That is what the girls choose to call the chemo chair. Jamie always brightens Mary Jo's day.
Diane received on Monday the good news from her BRCA2 genetic test result that no mutation was detected. This confirms that Mary Jo's mom was not the carrier of the BRCA2 gene mutation which Mary Jo and her sister Michelle inherited and now confirmed from her father. Mary Jo's father could not be tested because he died from liver cancer in 1997. His only brother Dick, died from stomach cancer several years ago and his only sister, we believe is still a breast cancer survivor living in Florida somewhere but has not been in contact with the family in years. The good news is Diane does not have to be concerned anymore than the general population regarding her odds of getting breast or ovarian cancer. Another benefit of knowing the origin of the mutation is the knowledge that can be shared with family members (cousins) on Mary Jo's dad's side. Statically those cousins could likely be carriers of the same gene mutation and early testing/detection could save someone life. Breast cancer advancements in recent years are simple remarkable.
Mary Jo had her weekly Herceptin treatment on Monday morning at Dr. Gall's, Minnesota Oncology office. This week she tolerated the Herceptin well with little of the adverse side effects. Next Monday, Mary Jo will be given chemo treatment number five of "TC" (Taxotere and Carboplatian, the main chemo agents along with Aloxi, Dexameth, Amend, and Newlasta as boosters). This will be the fifth cycle of the eight cycle regiment.
Mary Jo's mom, Diane was there as usual on Monday, to sit with MJ and I to keep us company during the Herceptin treatment. Diane has been so supportive to us through this whole process. It was also good to see Mary Jo's good friend Jamie at the "spa". That is what the girls choose to call the chemo chair. Jamie always brightens Mary Jo's day.
Diane received on Monday the good news from her BRCA2 genetic test result that no mutation was detected. This confirms that Mary Jo's mom was not the carrier of the BRCA2 gene mutation which Mary Jo and her sister Michelle inherited and now confirmed from her father. Mary Jo's father could not be tested because he died from liver cancer in 1997. His only brother Dick, died from stomach cancer several years ago and his only sister, we believe is still a breast cancer survivor living in Florida somewhere but has not been in contact with the family in years. The good news is Diane does not have to be concerned anymore than the general population regarding her odds of getting breast or ovarian cancer. Another benefit of knowing the origin of the mutation is the knowledge that can be shared with family members (cousins) on Mary Jo's dad's side. Statically those cousins could likely be carriers of the same gene mutation and early testing/detection could save someone life. Breast cancer advancements in recent years are simple remarkable.
.jpg)
.jpg)
.jpg)
.jpg)
1 comment:
Mary Jo - You still look so beautiful.... I am glad you are as far along as you are in your treatment. You just look wonderful. Renee H. King
Post a Comment